Oxford Group of Institutions is widely regarded as one of the top colleges in Haridwar and Uttarakhand for pursuing the Bachelor of Pharmacy (B.Pharam) degree. Located at the prime location of Navodaya Chowk, Roshnabad in Haridwar, Oxford Group of Institutions has established itself as a leading institution for high-quality technical education in the region.
B.Pharma is a four-year undergraduate degree program that focuses on the study of pharmaceutical sciences. It prepares students for various roles in the pharmacy sector, including research, manufacturing, and clinical practice.
Eligibility
- Educational Qualification: Completion of 10+2 (or equivalent) with Physics, Chemistry, and Biology/Mathematics from a recognized board.
- Minimum Marks: Typically, a minimum of 50% in the qualifying examination, though this can vary by institution.
- Entrance Exams: Admission is often based on entrance exams such as NEET, BITSAT, MHT CET, etc
Duration
- The course spans four years, divided into eight semesters
Syllabus
The syllabus covers a wide range of subjects, including:
- Pharmaceutics: Study of drug formulation and dispensing.
- Pharmaceutical Chemistry: Basics of medicinal chemistry and drug interactions.
- Pharmacology: Understanding drug actions and effects on the body.
- Pharmacognosy: Study of medicinal plants and natural products.
- Biochemistry: Basics of biochemistry and its clinical applications.
- Human Anatomy and Physiology: Understanding the human body and its functions.
- Industrial Pharmacy: Focus on the manufacturing and quality control of pharmaceuticals
Key Benefits
- Career Opportunities: Graduates can work as pharmacists, clinical researchers, medical representatives, or in pharmaceutical companies.
- Further Studies: It serves as a foundation for higher education in pharmacy, such as M.Pharma or Ph.D.
- Industry Demand: There is a consistent demand for qualified pharmacists in hospitals, clinics, and pharmaceutical companies.
- Research Opportunities: Graduates can engage in research and development of new drugs and therapies